Müge GÜLEN, Halit KARAKISA, Mürsel KOÇER, Akkan AVCI

Hiperamilazemi

Amilaz karın ağrısı olan hastaların ayırıcı tanısında sıklıkla kullanılan, hızlı, ucuz, basit bir laboratuvar testi aracılığıyla ölçülür. Pankreatitin yanı sıra gastrointestinal, jinekolojik, renal, kardiyovasküler, nörolojik nedenli birçok hastalıkta da yükselebilmesi nedeniyle amilaz yüksekliği saptanan hastaların klinik durumu da mutlaka değerlendirmeye alınmalıdır. Bu yazıda hekimlerin hipermamilazemi saptadıkları hastalarda ayırıcı tanıda yer alması gereken hastalıklara ve hiperamilazemi patogenezine güncel bilgilerle katkıda bulunmak amaçlanmıştır

Hyperamylasemia

Amylase is measured with a rapid, easy and cheap laboratory test which is usually used in the differential diagnosis of the patients with abdominal pain. In addition to pancreatitis amilaz may increase in gastrointestinal, gynecologic, renal, cardiovascular and neurologic diseases so clinical situation of the patient should be assesed. In this article we intended to contribute clinicians knowledge about differential diagnosis of the patients with hyperamylasemia and pathogenesis of hyperamylasemia with current informations

PDF

___

1. Salt WB, Schenker S. Amylase-It's clinical significance: areview of the literature. Medicine.1976; 55:269-89.
2. Leclerc P, Forest JC. Variations in amylase isoenzymes and lipase during acute pancreatitis, and in other disorders causing hyperamylasemia.Clin. Chem. 1983; 29:1020-23.
3. Fung W, Murray R, Masarei J, Tan E. P3 amylase isoenzyme in patients with cholelithiasis. Am J Gastroenterol. 1981; 76:52-5.
4. Zakowski J, Bruns D. Biochemistry of human alpha amylase isoenzymes. Crit Rev Clin Lab Sci. 1985; 21:283-322.
5. Davidsohn I, Henry JB, Todd JC. Todd-Sanford Clinical Diagnosis by Laboratory Methods. Philadelphia, W. B. Saunders Co,1974.
6. Fridhandler L, Berk JE, Ueda M. Isolation and measurement of pancreatic amylase in human serum and urine. 1972; 18:1493-97.
7. Sinha S, Khan H, Timms PM, Olagbaiye OA. Pancreatic-type hyperamylasemia and hyperlipasemia secondary to ruptured ovarian cyst: a case report and review of the literature. J Emerg Med. 2010; 38:463-6.
8. Feldman M, Friedman LS, Brandt LJ. Sleisenger and Fordtran’s Gastrointestinal andLiver Disease. 9. Baskı. Philadelphia,Saunders Elsevier,2010.
9. Berk JE. Serum amylase and lipase: newer perspectives. JAMA. 1967;199:98-102.
10. Levitt MD, Ellis CJ. Measurement of serum amylase, urinary amylase and clearance amylase/creatinine using a protein containing chromogenic substrate. Am J Gastroenterol. 1979;2:60-4.
11. Ceska M, Brown B, Birath K. Ranges of alpha-amylase activities in human serum and urine and correlations with some other alpha amylase methods. Clin Chim Acta. 1969;26:445-53.
12. Duane W, Frerichs R, Levitt MD. Distribution, turnover and mechanism of renal excretion of amylase in the baboon. JClin Invest. 1971; 50:156-65.
13. Duane W, Frerichs R, Levitt MD. Simultaneous study of the metabolic turnover and renal excretion of salivary amylase andpankreatic amylase in the baboon. J Clin Invest. 1972; 51:1504- 13.
14. Levitt MD, Ellis CJ. Serum isoamylase measurements in pancreatitis complicating chronic renal failure. J Lab Clin Med. 1979; 93:71-7.
15. Speirs R, Herring J, Cooper W, Hardy C, Hind C. The influence of sympathetic activity and isoprenaline on the secretion of amylase from the human parotid gland. Arch Oral Biol. 1974; 19:747-52.
16. Laurikainen K, Laurikainen E, Tenovuo J, Kaila T, Vilja P. Effects of a beta-blocking agent, timolol maleate, on saliva in healthy volunteers. Scand J Dent Res. 1988;96:121-7.
17. Van Stegeren A, Rohleder N, Everaerd W, Wolf O. Salivary alpha amylase as marker for adrenergic activity during stress: effect of betablockade. Psychoneuroendocrinology. 2006;31:137-41.
18. Ehlert U, Emi K, Hebisch G, Nater U. Salivary alpha-amylase levels after yohimbine challenge in healthy men. J Clin Endocrinol Metab. 2006;91:5130-3.
19. Pieper-Bigelow C, Strocchi A, Levitt MD. Where does serum amylase come from and where does it go?. Gastroenterol Clin North Am. 1990;19:793-810.
20. Egdahl RH. Mechanism of blood enzyme changes following the production of experimental pancreatitis. Ann Surg. 1958; 148:389-400.
21. Wilding P, Cooke WT, Nicholsın GI. Globulin-bound amylase: a couse of persistently elevated levels in serum. Ann Intern Med. 1964;6:1053-9.
22. Berk JE, Kizu H, Wilding P, Searcy RL. Macroamylasemia: a newly recognised cause for the elevated serum amylase activity. N Engl J Med. 1967;277:941-6.
23. Levitt MD, Cooperband SR. Hyperamilasemia from the binding of serum amylase by an 11S IgA globulin. N Engl J Med. 1968;292:474-9.
24. Berggren T, Levitt MD. An unusual form of macroamylasemia. Gastroenterology. 1974;67:149-54.
25. Barrows D, Berk JE, Fridhandler L. Macroamylasemia:surveyof prevalence in a mixed population. N Engl J Med. 1972;286:1352.
26. Helfat A, Berk JE, Fridhandler L. Prevalence of macroamylasemia: further study. Am J Gastroenterol. 1974; 62:54-8.
27. Dreiling DA, Leichtling JJ, Sanowitz HD. The amilaz-creatinine clearance ratio: Diagnostic parameter or physiologic phenomenon? Am. J. Gastroenreol. 1974; 61:290-6.
28. Lesser PB, Warshaw AL. Differentiation of pancreatitis from common bile duct obstruction with hyperamylasemia. Gastroenterology. 1975; 68:636-1.
29. Lesser PB, Warshaw AL. Diagnosis of pancreatitis masked by hyperlipemia. Ann Intern Med. 1975;82:795-8.
30. Warshaw AL, Fuller JAF. Specificity of increased renal clearence of amylase in diagnosis of acute pancreatitis. N Engl J Med. 1975;292:325-8.
31. Berk JE, Fridhandler L, Montgomery K. Simulation of macroamylasemia by salivary-type (s-type) hyperamylasemia. Gut. 1973;14:726-9.
32. Levitt MD, Papoport M, Cooperband SR. Renal clearance of amylase in renal insufficiency, acute pancreatitis, and macroamylasemia. Ann Intern Med. 1969;71:919-925.
33. Gelrud D, Gress FG. Approach to the patient with elevated serum amylase or lipase. Uptodate. Available www.uptodate.com. (Erişim Tarihi: 22 Ocak 2016).
34. Tenner S, Baillie J, DeWitt J, Vege SS. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2013;108:1400-15.
35. Agarwal N, Pitchumoni CS, Sivaprasad AV. Evaluating tests for acute pancreatitis. Am J Gastroenterol.1990;85:356-66.
36. McClatchey K. Clinical Laboratory Medicine, 2th ed. Baltimore MD, Williams and Wilkins, 1994.
37. Gumaste VV, Roditis N, Mehta D, Dave PB. Serum lipase levels in nonpancreatic abdominal pain versus acute pancreatitis. Am J Gastroenterol. 1993; 88:2051-5.
38. Sutton PA, Humes DJ, Purcell G, Smith JK, Whiting F, Wright T, et. al. The role of routine assays of serum amylase and lipase for the diagnosis of acute abdominal pain. Ann R Coll Surg Engl. 2009; 91:381-384.
39. Gumaste VV. Diagnostic tests for acute pancreatitis. Gastroenterologist. 1994; 2:119-130.
40. Orebaugh S. Normal amylase levels in the presentation of acute pancreatitis. Am J Emerg Med. 1994;12:21-4.
41. Lin X, Wang S, Tsai Y. Serum amylase, isoamylase and lipase in the acute abdomen: their diagnostic value for acute pancreatitis. J Clin Gastroenterol. 1989;11:47-52.
42. Çağlayan K, Köksal N, Onur E, Altınlı E, Çelik A, Sümer A et al. Pankreas yaralanmalarında sekiz yıllık deneyimimiz. Ulusal Travma Acil Cerrahi Dergisi. 2007;13:300-6.
43. Kavaklı B, Sargın M, Gümüş M. Diabetes mellitus’un akut metabolik komplikasyonları-1: diyabetik ketoasidoz. 1998;9:710-3.
44. Muniraj T, Dang S, Pitchumoni CS. Pancreatitis or not? elevated lipase and amylase in ICU patients. J Crit Care. 2015;30:1370-5.
45. Yadav D, Nair S, Norkus EP, Pitchumoni CS. Nonspecific hyperamylasemia and hyperlipasemia in diabetic ketoacidosis: incidence and correlation with biochemical abnormalities. Am J Gastroenterol. 2000; 95:3123-8.
46. Reed AM, Husain SZ, Thrower E, Alexandre M, Shah A, Gorelick FS et al. Low extracellular pH induces damage in the pancreatic acinar cell by enhancing calcium signaling. J Biol Chem. 2011;286:1919-26.
47. Haddad NG, Croffie JM, Eugster EA. Pancreatic enzyme elevations in children with diabetic ketoacidosis. J Pediatr. 2004;145:122-4.
48. Vantyghem MC, Haye S, Balduyck M, Hober C, Degand PM, Lefebvre J. Changes in serum amylase, lipase and leukocyte elastase during diabetic ketoacidosis and poorly controlled diabetes. Acta Diabetol. 1999;36:39-44.
49. Lee CC, Chung WY, Shih YH. Elevated amylase and lipase levels in the neurosurgery intensive care unit. J Chin Med Assoc. 2010;73:8-14.
50. Larson GM, Koch S, O'Dorisio TM, Osadehey B, McGraw P, Richardson JD. Gastric response to severe head injury. Am J Surg.1984; 147:97-105.
51. Cote GA, Gottstein JH, Daud A, Blei AT. The role of etiology in the hyperamylasemia of acute liver failure. Am J Gastroenterol.2009;104:592-7.
52. Lin XZ, Chen TW, Wang SS. Pancreatic enzymes in uremic patients with or without dialysis. Clin Biochem. 1988;21:189-192.
53. Jiang CF, Ng KW, Tan SW. Serum level of amylase and lipase in various stages of chronic renal insufficiency.Chin Med J. 2002;65:49-54.
54. Masoero G, Bruno M, Gallo L, Colaferro S, Cosseddu D, Vacha GM. Increased serum pancreatic enzymes in uremia: relation with treatment modality and pancreatic involvement. Pancreas. 1996;13:350-5.
55. Green CL. Identification of alpha-amylase as a secretion of the human fallopian tube and tubelike epithelium of Müllerian and mesonephric duct origin. Am J Obstet Gynecol.1957;73:402-8.
56. Eser A, Kaygusuz İ, Köşüş N, Köşüş A, Gümüş İİ. Obstetrik ve jinekolojide amilaz. Türkiye Klinikleri J Gynecol Obst. 2016;26:109-13.
57. Shen YS, Chan CM, Chen WL,Chen JH, Chang HY, Chu H et. al. Diagnostic performance of initial salivary alpha-amylase activity for acute myocardial infarction in patients with acute chest pain. J Emerg Med. 2012;43:553-60.
58. Nater UM, Rohleder N. Salivary alpha-amylase as a non-invasive biomarker for the sympathetic nervous system: current state of research. Psychoneuroendocrinology. 2009;34:486-96.
59. Shen YS, Chan CM, Chen WL,Chen JH, Chang HY, Chu H. Initial salivary α-amylase activity predicts malignant ventricular arrhythmias and short-term prognosis after ST-segment elevation myocardial infarction. Emer Med J. 2011;28:1041-5.

ISSN: 1300-3755
Yayın Aralığı: Yılda 4 Sayı
Başlangıç: 1992
Yayıncı: Çukurova Üniversitesi Tıp Fakültesi

Arşiv